Services

Drug Development
Guiding Clinical Trials
Preclinical animal models
SolidSense Assay™ solid tumor drug sensitivity diagnostic

Drug Development

EARLY DRUG DEVELOPMENT The QantaScope’s Hexascope family and broad range of reagent kits are highly suitable for use in early stage drug development. Library screening of different molecules can be scanned with a high throughput technology on our automated scanners. HexascopeHTP™ is designed for high throughput cell based work, while HexascopeHAEMA™ is aimed to be used, when primary cells from fresh patient samples are introduced at this early stage for lead development. Please contact our Drug...

Guiding Clinical Trials

GUIDING CLINICAL STUDIES IN PHASE 2&3 Drug development in oncology is a wide and challenging field. Screening of thousands and thousands of substances on a high throughput scale to generate a few possible drug candidate demands massive investments and is very time consuming. Therefore it is highly desirable that drugs which are in the pipeline in clinical trial Phase II or Phase III will generate the expected success rate. To improve the hit rate, both time and financial resources can be saved...

Preclinical animal models

PRECLINICAL TESTING As a part of our complete custom drug screening portfolio, animal models, IC50 calculations and TOX tests are available upon request. Please contact our Drug Development Team for further information and for possible custom applications.  Drug.Development@qantascope.com

SolidSense Assay™ solid tumor drug sensitivity diagnostic

SolidSense Assay™ Assay Guided Personalized Solid Tumor Therapy Treating solid tumors can be very challenging even though there are endless anti-cancer drugs in clinical use. QantaScope developed an advanced diagnostic technology where cancer cells are labelled with a specific OmniFluorBright™ (OFB) stain. As a result of this unique SolidSense Assay™ technology, drug sensitivity screening on solid tumors can be performed. Depending on the tumor size a number of anti-cancer drugs can be...